Quoin Pharmaceuticals Ltd Stock Probability of Future Stock Price Finishing Over 0.66
| QNRX Stock | USD 0.66 0.07 9.59% |
Quoin |
Quoin Pharmaceuticals Target Price Odds to finish over 0.66
The tendency of Quoin Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.66 | 90 days | 0.66 | about 46.68 |
Based on a normal probability distribution, the odds of Quoin Pharmaceuticals to move above the current price in 90 days from now is about 46.68 (This Quoin Pharmaceuticals Ltd probability density function shows the probability of Quoin Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Quoin Pharmaceuticals has a beta of 0.78 indicating as returns on the market go up, Quoin Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Quoin Pharmaceuticals Ltd will be expected to be much smaller as well. Additionally Quoin Pharmaceuticals Ltd has an alpha of 0.3627, implying that it can generate a 0.36 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Quoin Pharmaceuticals Price Density |
| Price |
Predictive Modules for Quoin Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Quoin Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Quoin Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Quoin Pharmaceuticals is not an exception. The market had few large corrections towards the Quoin Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Quoin Pharmaceuticals Ltd, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Quoin Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.36 | |
β | Beta against Dow Jones | 0.78 | |
σ | Overall volatility | 0.12 | |
Ir | Information ratio | 0.03 |
Quoin Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Quoin Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Quoin Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Quoin Pharmaceuticals is way too risky over 90 days horizon | |
| Quoin Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Quoin Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| Quoin Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| Quoin Pharmaceuticals Ltd currently holds 3.52 K in liabilities with Debt to Equity (D/E) ratio of 0.47, which is about average as compared to similar companies. Quoin Pharmaceuticals has a current ratio of 0.94, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Quoin Pharmaceuticals' use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (8.69 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Quoin Pharmaceuticals Ltd currently holds about 2.69 M in cash with (7.86 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.56. | |
| Latest headline from prnewswire.com: Jack Topdjian Joins eMerge Americas as Advisor for Health and Biotechnology Innovation Hub |
Quoin Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Quoin Stock often depends not only on the future outlook of the current and potential Quoin Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Quoin Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 900.9 K | |
| Cash And Short Term Investments | 10.7 M |
Quoin Pharmaceuticals Technical Analysis
Quoin Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Quoin Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Quoin Pharmaceuticals Ltd. In general, you should focus on analyzing Quoin Stock price patterns and their correlations with different microeconomic environments and drivers.
Quoin Pharmaceuticals Predictive Forecast Models
Quoin Pharmaceuticals' time-series forecasting models is one of many Quoin Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Quoin Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Quoin Pharmaceuticals
Checking the ongoing alerts about Quoin Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Quoin Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Quoin Pharmaceuticals is way too risky over 90 days horizon | |
| Quoin Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Quoin Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| Quoin Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| Quoin Pharmaceuticals Ltd currently holds 3.52 K in liabilities with Debt to Equity (D/E) ratio of 0.47, which is about average as compared to similar companies. Quoin Pharmaceuticals has a current ratio of 0.94, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Quoin Pharmaceuticals' use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (8.69 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Quoin Pharmaceuticals Ltd currently holds about 2.69 M in cash with (7.86 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.56. | |
| Latest headline from prnewswire.com: Jack Topdjian Joins eMerge Americas as Advisor for Health and Biotechnology Innovation Hub |
Additional Tools for Quoin Stock Analysis
When running Quoin Pharmaceuticals' price analysis, check to measure Quoin Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quoin Pharmaceuticals is operating at the current time. Most of Quoin Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Quoin Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quoin Pharmaceuticals' price. Additionally, you may evaluate how the addition of Quoin Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.